Patent Assignment
Reel/Frame 063409/0528
Change of Name
Recorded: 2023-04-21
Pages: 2
Assignor
CELL THERAPEUTICS, INC.
Executed: 2014-06-04
Assignee
CTI BIOPHARMA CORP.
3101 WESTERN AVE., SUITE 800, SEATTLE, WASHINGTON, 98121
Covered Property
(1)
11-(2-Pyrrolidin-1-Yl-Ethoxy)-14,19-Dioxa-5,7,26-Triaza-Tetracyclo[19.3.1.1(2,6).1(8,12)]Heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-Decaene Citrate Salt
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 21, 2023
From: DYMOCK, BRIAN; LEE, CHENG H.; WILLIAM, ANTHONY D.
To: S*BIO PTE LTD.
Reel/Frame 063405/0462 →
Assignment of Assignor's Interest
Apr 21, 2023
From: S*BIO PTE LTD.
To: CELL THERAPEUTICS, INC.
Reel/Frame 063405/0484 →
Merger
Oct 3, 2024
From: CTI BIOPHARMA CORP.
To: SOBI, INC.
Reel/Frame 068782/0512 →